Jessica Sachs serves as Executive at Cogent Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Jessica Sachs has executed 6 insider transactions totaling $3.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 26, 2025 involved selling 82,642 shares valued at $3.2M.
Jessica Sachs currently holds 133,938 shares of Cogent Biosciences, Inc. (COGT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jessica Sachs has been a net seller of COGT stock. They have purchased $0 and sold $3.2M worth of shares.
Jessica Sachs's most recent insider trade was on Dec 26, 2025, when they sold 82,642 shares at $38.70 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 17, 2025 | COGT | $0 | Award | 320,000 | $N/A | Discretionary |
| Dec 17, 2025 | COGT | $6.1M | Payment | 154,716 | $39.45 | Discretionary |
| Jun 30, 2022 | COGT | $4.6K | Award | 622 | $7.40 | Discretionary |
| Dec 31, 2021 | COGT | $4.6K | Award | 674 | $6.82 | Discretionary |